TTBK1 and Alzheimer disease: The present results indicate that inhibiting TDP-43 phosphorylation in human cell models of AD, by targeting TTBK1 or CK1 is enough not only to recover nuclear TDP-43 localization, but also to reduce the cytotoxic effect of protein aggregates in intracellular transport.